Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1988 Jun;57(6):608-11.
doi: 10.1038/bjc.1988.138.

Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. 'Nolvadex' Adjuvant Trial Organisation

No authors listed
Free PMC article
Clinical Trial

Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. 'Nolvadex' Adjuvant Trial Organisation

No authors listed. Br J Cancer. 1988 Jun.
Free PMC article

Abstract

At a maximum follow up of 8 years (median 5 years 6 months) in a randomised trial of adjuvant tamoxifen versus no treatment as therapy for early breast cancer, a significant advantage persists for patients receiving 20 mg of tamoxifen daily for 2 years. This advantage is independent of menopausal status, stage, grade and ER status. Log hazard rate analysis fails to demonstrate a rebound effect on stopping the drug and suggests that more prolonged treatment might further improve results.

PubMed Disclaimer

References

    1. Br J Cancer. 1978 Sep;38(3):428-30 - PubMed
    1. Cancer Res. 1983 Sep;43(9):3998-4006 - PubMed
    1. Biochem Biophys Res Commun. 1984 Jan 13;118(1):27-32 - PubMed
    1. Recent Results Cancer Res. 1984;91:98-103 - PubMed
    1. Cancer Res. 1987 May 1;47(9):2508-13 - PubMed

Publication types